We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Venn Life Sciences Holdings Plc | LSE:VENN | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.85 | 6.70 | 7.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMVENN
RNS Number : 0838O
Venn Life Sciences Holdings PLC
02 November 2016
Venn Life Sciences Holdings Plc
("Venn Life Sciences" or the "Company")
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Hot Features
Premium
1 Details of the person discharging managerial
responsibilities / person closely associated
----- --------------------------------------------------------------------
a) Name Allan Wood
----- ----------------------------- -------------------------------------
2 Reason for the notification
----- --------------------------------------------------------------------
a) Position/status Chairman (PDMR)
----- ----------------------------- -------------------------------------
b) Initial notification Initial Notification
/Amendment
----- ----------------------------- -------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
----- --------------------------------------------------------------------
a) Name Venn Life Science Holdings
PLC
b) LEI code
Pending
----- ----------------------------- -------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
----- --------------------------------------------------------------------
a) Description of Ordinary Shares of nominal
the financial value of 0.1 pence each
instrument, type
of instrument
-----
Identification ISIN GB00B9275X97
code
b) Nature of the Acquisition of ordinary shares
transaction
----- ----------------------------- -------------------------------------
c) Price(s) and volume(s)
----- ------------------ --------------
Price(s) Volume(s)
----- ------------------ --------------
21.50p per
share 65,000
------------------------------------------------------ --------------
21.73p per
share 165,000
------------------------------------------------------ --------------
d) Aggregated information
-----
- Aggregated volume 230,000
- Price 21.67 pence per share
e) Date of the transaction 31 October 2016
----- ----------------------------- -------------------------------------
f) Place of the transaction London Stock Exchange AIM
market
----- ----------------------------- -------------------------------------
Venn Life Sciences Holdings www.vennlifesciences.com
Plc
Tony Richardson, Chief Executive Tel: +353 154 99 341
Officer
Davy (Nominated Adviser, ESM
Adviser and Joint Broker)
Fergal Meegan / Matthew de Vere Tel: +353 1 679 6363
White (Corporate Finance)
Paul Burke (Corporate Broking)
Hybridan LLP (Co-Broker)
Claire Louise Noyce Tel: +44(0)20 3764 2341
Walbrook PR Ltd Tel: +44(0)20 7933 8787 or
venn@walbrookpr.com
Paul McManus Mob: +44(0) 7980 541 893
Lianne Cawthorne Mob: +44(0) 7854 391 303
About Venn Life Sciences: Venn Life Sciences is a Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn also has an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLIFIDLLLFIIR
(END) Dow Jones Newswires
November 02, 2016 03:03 ET (07:03 GMT)
1 Year Venn Life Sciences Chart |
1 Month Venn Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
